Skip to main content
Deutsch

Detailansicht Person

  1. Medical Neuroscience Cluster
  2. About Us
  3. Members
  4. People
  5. Detailansicht Person
Sorry, this content is only available in German!
Rupert Lanzenberger
Univ.-Prof. Priv.-Doz. Dr.med. Rupert Lanzenberger

Division of General Psychiatry (Department of Psychiatry and Psychotherapy)
Position: Professor

Phone: +43 1 40400-35760
E-Mail: rupert.lanzenberger@meduniwien.ac.at

Research Area

Functional Magnetic Resonance, Neuroimaging, Positron-Emission Tomography

Research Interests

addiction, Alzheimer Disease, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Biological Psychiatry, Cerebral Cortex, Cognitive Science, Consciousness, Depression, Diffusion Magnetic Resonance Imaging, Epigenomics, Functional Neuroimaging, Genome-Wide Association Study, Gonadal Steroid Hormones, Magnetic Resonance Imaging, Mental Disorders, Mood Disorders, Multimodal Imaging, Neuropsychiatry, Obsessive-Compulsive Disorder, Polymorphism, Genetic, Positron-Emission Tomography, Psychopharmacology, Schizophrenia, Stress, Physiological, Transsexualism, Ultrahigh field MRI

Principle Investigator(s)

  • Lanzenberger, Rupert (Head)
  • Kasper, Siegfried

    • Interest Group(s)

  • Neuroimaging (Head)
  • AddRess - Center for Addiction Research & Science
  • Neurobiology of Emotion and Cognition
  • Neuropsychopharmacology

    • Grant(s)

  • Effects of Electroconvulsive Therapy on Monoamine Oxidase A distribution volume in treatment-resistant depression investigated with PET (Head)
  • The Norepinephrine Transporter in Attention Deficit Hyperactivity Disorder investigated with PET (Head)
  • Effects of sex steroid hormones on serotonin synthesis and degradation measured with PET (Head)
  • Enhancement of learning associated neural plasticity by Selective Serotonin Reuptake Inhibitors (Head)
  • Multimodal Neuroimaging in Clinical Neurosciences – Assessment of neurobiological markers for psychiatric disorders (Head)

    • Selected publications

    1. Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R (2013) Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET Mol Psychiatry, 18 (1): 93-100
    2. Hahn A, Wadsak W, Windischberger C, Baldinger P, Hoflich A, Losak J, Nics L, Philippe C, Kranz G, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R (2012) Differential modulation of the default mode network via serotonin-1A receptors PNAS, 109 (7): 2619-2624
    3. Savli M, Bauer A, Mitterhauser M, Ding Y, Hahn A, Kroll T, Neumeister A, Haeusler D, Ungersboeck J, Henry S, Isfahani S, Rattay F, Wadsak W, Kasper S, Lanzenberger R (2012) Normative database of the serotonergic system in healthy subjects using multi-tracer PET Neuroimage, 63 (1): 447-459
    4. Spindelegger C, Lanzenberger R, Wadsak W, Mien L, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S (2009) Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders Mol Psychiatry, 14 (11): 1040-1050
    5. Lanzenberger R, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. (2007) Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder. Biol Psychiatry, 61(9): 1081-9

    Show all publications